Jay Kincannon

Professor

University of Arkansas for Medical Sciences

faculty

Dermatology, College of Medicine

12 h-index 32 pubs 1,216 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Jay Kincannon, M.D. is a Professor of Dermatology and Pediatrics at the University of Arkansas for Medical Sciences and Chief of Pediatric Dermatology at Arkansas Children's Hospital. His research and clinical work focuses on the diagnosis and treatment of skin conditions in children. Dr. Kincannon has served in interim leadership roles within the Department of Dermatology, including Interim Chairman from 2007-2009 and again in 2014-2015. He holds a Bachelor of Science in Zoology and a medical degree from the University of Arkansas for Medical Sciences.

His academic activities include a focus on treatment adherence in pediatric atopic dermatitis, with recent publications exploring this topic through systematic review. He has also investigated prurigo nodularis clinical trials, rare dermatological presentations such as annular erythema of infancy, and the clinical significance of propranolol administration for infantile hemangiomas. Dr. Kincannon's work extends to genetic and metabolic disorders manifesting in the skin, including cutaneous oxalosis and novel compound heterozygous mutations in ILNEB syndrome. His scholarship metrics include an h-index of 12, 32 total publications, and 1,216 total citations. He leads a research group and collaborates with colleagues at the University of Arkansas for Medical Sciences, including Sara Shalin, Austin Morgan, Sophia Ly, and Megan S. Evans.

Research Overview

Jay Michael Kincannon, M.D. is a staff physician and Professor of Dermatology and Pediatrics in the Department of Dermatology at the University of Arkansas for Medical Sciences and Chief of Pediatric Dermatology at Arkansas Children's Hospital. Dr. Kincannon previously served as Interim Chairman of the Department of Dermatology between 2007-2009 and again in 2014-2015.Dr. Kincannon graduated with a Bachelor of Science degree in Zoology from the University of Arkansas at Fayetteville and received his medical degree from the University of Arkansas for Medical Sciences in 1985. His internship in Pediatrics was completed at the University of Colorado School of Medicine where he also completed residency training in both Pediatrics and Dermatology.Dr. Kincannon is an active member in several national academic organizations including the American Academy of Dermatology, the Pediatric Dermatology Society and the American Medical Association. He was the 1997 president of the Arkansas Dermatology Society. He has served on numerous committees and boards for academia and has presented at national and international summits. He is a member of Alpha Omega Alpha Honor Medical Society, and he has received yearly UAMS teaching awards, including receiving the Residency Educator Golden Apple Award numerous times.His research interests include vascular and pigmented skin lesions, birthmarks, pediatric skin diseases, human papilloma virus immunotherapy, vitiligo and cutaneous laser therapy. He cares for both adults and children at the UAMS Medical Center Dermatology Clinic. As section chief of pediatric dermatology at Arkansas Children's Hospital, he cares for the full spectrum of childhood skin disorders including treatment of vascular birth marks.Dr. Kincannon is board certified by the American Board of Pediatrics and the American Board of Dermatology.

Metrics

  • h-index: 12
  • Publications: 32
  • Citations: 1,216

Selected Publications

  • Novel Compound Heterozygous Mutations in ILNEB Syndrome (2025) DOI
  • Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review (2024) DOI
  • Landscape of prurigo nodularis clinical trials (2024) DOI
  • Corymbiform cutaneous disorders in pediatric dermatology: <scp>Exploring</scp> this pattern of presentation beyond secondary syphilis (2024) DOI
  • Annular erythema of infancy: A rare and challenging diagnosis (2023) DOI
  • Cutaneous Oxalosis Due to Primary Hyperoxaluria (2022) DOI
  • Hyperkeratotic Plaques of Distal Extremities as a Presenting Sign of Autoimmune Hepatitis: Answer (2021) DOI
  • Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas (2021) DOI

Grants & Funding

  • Immunex Protocol No. 20040210 entitled Observational Post-Marketing Safety Surveillance Registry of Enbrel (etanercept) for the Treatment of Psoriasis Immunex Corporation Principal Investigator

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics